These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 37523844)

  • 1. Perspectives and recommendations of opioid overdose survivors experiencing unsheltered homelessness on housing, overdose, and substance use treatment in Boston, MA.
    Paradise RK; Desmarais J; O'Malley SE; Hoyos-Cespedes A; Nurani A; Walley AY; Clarke J; Taylor S; Dooley D; Bazzi AR; Kimmel SD
    Int J Drug Policy; 2023 Sep; 119():104127. PubMed ID: 37523844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multilevel Factors Impacting Substance Use Treatment Access, Engagement, and Racial Equity Among Opioid Overdose Survivors in Boston, MA.
    Paradise RK; Bazzi AR; Clarke J; Desmarais J; Hoyos-Cespedes A; Nurani A; O'Malley SE; Taylor S; Walley AY; Dooley D; Kimmel SD
    J Gen Intern Med; 2024 Oct; 39(13):2390-2399. PubMed ID: 38997532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug Overdose Mortality Among People Experiencing Homelessness, 2003 to 2018.
    Fine DR; Dickins KA; Adams LD; De Las Nueces D; Weinstock K; Wright J; Gaeta JM; Baggett TP
    JAMA Netw Open; 2022 Jan; 5(1):e2142676. PubMed ID: 34994792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population-Level Health Effects of Involuntary Displacement of People Experiencing Unsheltered Homelessness Who Inject Drugs in US Cities.
    Barocas JA; Nall SK; Axelrath S; Pladsen C; Boyer A; Kral AH; Meehan AA; Savinkina A; Peery D; Bien M; Agnew-Brune C; Goldshear J; Chiang J; Linas BP; Gonsalves G; Bluthenthal RN; Mosites E;
    JAMA; 2023 May; 329(17):1478-1486. PubMed ID: 37036716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid-related overdose deaths among people experiencing homelessness, 2017 to 2021: A population-based analysis using coroner and health administrative data from Ontario, Canada.
    Booth RG; Shariff SZ; Carter B; Hwang SW; Orkin AM; Forchuk C; Gomes T
    Addiction; 2024 Feb; 119(2):334-344. PubMed ID: 37845790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Sick and tired of being sick and tired": Exploring initiation of medications for opioid use disorder among people experiencing homelessness.
    Swartz N; Adnan T; Peréa F; Baggett TP; Chatterjee A
    J Subst Abuse Treat; 2022 Jul; 138():108752. PubMed ID: 35277306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. City streetscapes and neighborhood characteristics of fatal opioid overdoses among people experiencing homelessness who use drugs in New York City, 2017-2019.
    Nesoff ED; Wiebe DJ; Martins SS
    Int J Drug Policy; 2022 Dec; 110():103904. PubMed ID: 36370513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug use, homelessness and health: responding to the opioid overdose crisis with housing and harm reduction services.
    Milaney K; Passi J; Zaretsky L; Liu T; O'Gorman CM; Hill L; Dutton D
    Harm Reduct J; 2021 Aug; 18(1):92. PubMed ID: 34446034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "I don't think of it as a shelter. I say I'm going home": a qualitative evaluation of a low-threshold shelter for women who use drugs.
    Beaugard CA; Khudairi F; Yesufu O; Farina A; Laks J
    Harm Reduct J; 2024 Feb; 21(1):44. PubMed ID: 38374063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A peer-delivered intervention to reduce harm and improve the well-being of homeless people with problem substance use: the SHARPS feasibility mixed-methods study.
    Parkes T; Matheson C; Carver H; Foster R; Budd J; Liddell D; Wallace J; Pauly B; Fotopoulou M; Burley A; Anderson I; MacLennan G
    Health Technol Assess; 2022 Feb; 26(14):1-128. PubMed ID: 35212621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring opioid use disorder, its impact, and treatment among individuals experiencing homelessness as part of a family.
    Chatterjee A; Yu EJ; Tishberg L
    Drug Alcohol Depend; 2018 Jul; 188():161-168. PubMed ID: 29778009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facilitating exit from encampments: combining low-barrier transitional housing with stabilizing treatment for substance related problems.
    Komaromy M; Stone A; Peterson A; Gott J; Koenig R; Taylor JL
    Addict Sci Clin Pract; 2023 Oct; 18(1):66. PubMed ID: 37884986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Housing status and accidental substance-related acute toxicity deaths in Canada, 2016-2017.
    VanSteelandt A; Abele B; Ahmad R; Enns A; Jackson B; Kakkar T; Kouyoumdjian F
    Health Promot Chronic Dis Prev Can; 2024 Aug; 44(7-8):319-330. PubMed ID: 39141615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "No home to take methadone to": Experiences with addiction services during the COVID-19 pandemic among survivors of opioid overdose in Boston.
    Harris MTH; Lambert AM; Maschke AD; Bagley SM; Walley AY; Gunn CM
    J Subst Abuse Treat; 2022 Apr; 135():108655. PubMed ID: 34772604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Housing Instability, Structural Vulnerability, and Non-Fatal Opioid Overdoses Among People Who Use Heroin in Washington Heights, New York City.
    Pérez-Figueroa RE; Obonyo DJ; Santoscoy S; Surratt HL; Lekas HM; Lewis CF; Lyons JS; Amesty SC
    Behav Med; 2022; 48(4):320-330. PubMed ID: 34086534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homelessness and polysubstance use: A qualitative study on recovery and treatment access solutions around an urban library in Southern California, USA.
    Nicholls MJ; Urada LA
    Health Soc Care Community; 2022 Jan; 30(1):e175-e183. PubMed ID: 33988284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlates of experiencing and witnessing non-fatal opioid overdoses among individuals accessing harm reduction services in Philadelphia, Pennsylvania.
    Pizzicato LN; Johnson CC; Viner KM
    Subst Abus; 2020; 41(3):301-306. PubMed ID: 31644397
    [No Abstract]   [Full Text] [Related]  

  • 18. "We have to be uncomfortable and creative": Reflections on the impacts of the COVID-19 pandemic on overdose prevention, harm reduction & homelessness advocacy in Philadelphia.
    Aronowitz SV; Engel-Rebitzer E; Lowenstein M; Meisel Z; Anderson E; South E
    SSM Qual Res Health; 2021 Dec; 1():100013. PubMed ID: 34870265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline characteristics of people experiencing homelessness with a recent drug overdose in the PHOENIx pilot randomised controlled trial.
    Lowrie R; McPherson A; Mair FS; Stock K; Jones C; Maguire D; Paudyal V; Duncan C; Blair B; Lombard C; Ross S; Hughes F; Moir J; Scott A; Reilly F; Sills L; Hislop J; Farmer N; Lucey S; Wishart S; Provan G; Robertson R; Williamson A
    Harm Reduct J; 2023 Apr; 20(1):46. PubMed ID: 37016418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substance consumption and intoxication patterns in a medically supervised overdose prevention program for people experiencing homelessness.
    Wishik G; Gaeta JM; Racine MW; O'Connell JJ; Baggett TP
    Subst Abus; 2021; 42(4):851-857. PubMed ID: 33617749
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.